**Core Concept**
Vitiligo is a chronic autoimmune skin condition characterized by the loss of melanocytes, leading to depigmented patches. The exact pathogenesis is not fully understood, but it is believed to involve a combination of genetic predisposition and environmental triggers, resulting in an autoimmune response against melanocytes.

**Why the Correct Answer is Right**
The correct answer is **.** because it accurately describes the histopathological feature of vitiligo. In vitiligo, there is a selective destruction of melanocytes, which are the pigment-producing cells in the skin. This destruction is thought to be mediated by autoreactive T cells that target melanocytes, leading to a loss of pigment-producing cells and the characteristic white patches.

**Why Each Wrong Option is Incorrect**
**Option A:** This is incorrect because it does not accurately describe the histopathological feature of vitiligo. While there may be some inflammatory cells present in the affected skin, the primary feature is the loss of melanocytes.
**Option B:** This is incorrect because it is a feature of another condition, not vitiligo. In psoriasis, there is an overproduction of keratinocytes, leading to thickening of the skin.
**Option C:** This is incorrect because it is a feature of another condition, not vitiligo. In leprosy, there is a destruction of nerve endings, leading to sensory loss and skin lesions.

**Clinical Pearl / High-Yield Fact**
One important clinical correlation to remember is that vitiligo can be associated with other autoimmune conditions, such as thyroid disease, pernicious anemia, and type 1 diabetes. This is because the underlying autoimmune mechanism that leads to vitiligo may also contribute to the development of these other conditions.

**Correct Answer:** D.